Jennifer Sassano
About Jennifer Sassano
Jennifer Sassano is the Associate Director of Finance for Worldwide Commercial at Bristol-Myers Squibb, with over 20 years of experience in the pharmaceutical and healthcare industries.
Company
Jennifer Sassano is currently working at Bristol-Myers Squibb as the Associate Director, Finance - Worldwide Commercial in New Jersey, United States. Bristol-Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Jennifer Sassano holds the position of Associate Director, Finance - Worldwide Commercial at Bristol-Myers Squibb. In this role, she is responsible for overseeing financial operations on a global scale, contributing to the company's commercial strategy and financial performance.
Education and Expertise
Jennifer Sassano has a Master of Business Administration with a focus on Management and Healthcare from the University of Phoenix, completed between 2003 and 2008. She also holds a Bachelor of Science in Accounting from Rowan University, completed between 1992 and 1996. With over 20 years of experience in the pharmaceutical and healthcare industries, she has extensive expertise in financial reporting, analysis, and commercial finance.
Background
Jennifer Sassano has a robust background in finance, having worked in multiple managerial roles at Bristol-Myers Squibb and Merck. She served as a Senior Finance Manager, Finance Manager, and Senior Financial Analyst at Merck in Kenilworth, New Jersey, from 2003 to 2011. Additionally, she worked internationally as a Senior Financial Analyst at L'Oréal in Paris, France, from 2001 to 2003. Her diversified roles have provided her with a comprehensive understanding of financial operations within the pharmaceutical industry.
Achievements
Jennifer Sassano has held multiple key positions at Bristol-Myers Squibb for over a decade, being instrumental in various financial and commercial operations. Notably, she was the Associate Director, Finance Reporting Coe from 2014 to 2017, and Manager, Business Financial Services Rtr from 2013 to 2014. Her career path reflects a strong background in business financial services, pharmaceutical HQ analysis, and a profound understanding of the US pharmaceutical market.